Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation

Michael R. Charlton, William J. Wall, Akinlolu O. Ojo, Pere Ginés, Stephen Textor, Fuad S. Shihab, Paul Marotta, Marcelo Cantarovich, James D. Eason, Russell H. Wiesner, Michael A. Ramsay, Juan C. Garcia‐Valdecasas, James M. Neuberger, Sandy Feng, Connie L. Davis, Thomas A. Gonwa – 28 October 2009

Exaggerated up‐regulation of tumor necrosis factor α–dependent apoptosis in the older mouse liver following reperfusion injury: Targeting liver protective strategies to patient age

Markus Selzner, Nazia Selzner, Limin Chen, Ivan Borozan, Jing Sun, Max Xue‐Zhong, Jianhua Zhang, Ian D. McGilvray – 28 October 2009 – Although it is becoming increasingly common to accept livers from older donors for transplantation, old livers are more damaged by hepatic ischemia and reperfusion injury (HIRI) than young livers. We hypothesized that this age‐related susceptibility to HIRI is due to increased hepatocellular apoptosis driven by tumor necrosis factor α (TNFα).

Is the immediate reversal of diastolic dysfunction of cirrhotic cardiomyopathy after liver transplantation a sign of the metabolic etiology?

Kyota Fukazawa, Edward Gologorsky, Vinaya Manmohansingh, Seigo Nishida, Michael M. Vigoda, Ernesto A. Pretto – 28 October 2009 – Cirrhotic cardiomyopathy currently is believed to be a multifactorial entity. This communication describes a case of immediate intraoperative recovery of diastolic function following liver transplantation. This suggests that an underlying metabolic inhibition of myocardial metabolism is an important factor in the development of cardiomyopathy in end‐stage liver disease. Liver Transpl 15:1417–1419, 2009. © 2009 AASLD.

Factors influencing liver transplant length of stay at two large‐volume transplant centers

W. Kenneth Washburn, Nicholas A. Meo, Glenn A. Halff, John P. Roberts, Sandy Feng – 28 October 2009 – Length of stay (LOS) is considered a reliable surrogate for liver transplant resource utilization. Little information exists about how donor and recipient variables interact to affect transplant LOS. Data for adult, non–status 1 transplants (1998–2005), including the donor risk index (DRI) and Model for End‐Stage Liver Disease (MELD) scores, were collected from 2 institutions (n = 745 for center A and n = 710 for center B).

Primary biliary cirrhosis after liver transplantation: Influence of immunosuppression and human leukocyte antigen locus disparity

Pinelopi Manousou, Vasiliki Arvaniti, Emmanuel Tsochatzis, Graziella Isgro, Kate Jones, Graham Shirling, Amar P. Dhillon, James O'Beirne, David Patch, Andrew K. Burroughs – 28 October 2009 – Patients with primary biliary cirrhosis (PBC), despite excellent outcomes after liver transplantation (LT), may develop recurrent primary biliary cirrhosis (rPBC). The impact of immunosuppression and HLA mismatches on rPBC is unclear. We evaluated 103 consecutive PBC patients who underwent transplantation (follow‐up ≥ 10 months) with serial protocol biopsies.

Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients

Sven Pischke, Pothakamuri V. Suneetha, Christine Baechlein, Hannelore Barg‐Hock, Albert Heim, Nassim Kamar, Jerome Schlue, Christian P. Strassburg, Frank Lehner, Regina Raupach, Birgit Bremer, Peter Magerstedt, Markus Cornberg, Frauke Seehusen, Wolfgang Baumgaertner, Juergen Klempnauer, Jacques Izopet, Michael P. Manns, B. Grummer, Heiner Wedemeyer – 28 October 2009 – Hepatitis E virus (HEV) infection induces self‐limiting liver disease in immunocompetent individuals. Cases of chronic hepatitis E have recently been identified in organ transplant recipients.

Hepatitis C virus infection after liver transplantation is associated with lower levels of activated CD4+CD25+CD45RO+IL‐7rαhigh T cells

Donatella Ciuffreda, Laura Codarri, Leo Buhler, Laure Vallotton, Emiliano Giostra, Gilles Mentha, Philippe Morel, Giuseppe Pantaleo, Manuel Pascual – 28 October 2009 – The expression of interleukin 7 receptor alphahigh (IL‐7Rαhigh) discriminates between activated CD25+CD45RO+CD4+ T cells [IL‐7Rαhigh and forkhead box P3–negative (FoxP3−)] and regulatory T cells (IL‐7Rαlow and FoxP3+). The IL‐7RαhighCD25+CD45RO+CD4+FoxP3− T cell population has been shown to be expanded in the blood and tissues of patients after kidney transplantation and to contain alloreactive T cells (activated T cells).

Simplifying hepatic venous outflow reconstruction in sequential living donor liver transplantation

See Ching Chan, Chung Mau Lo, Kelvin K. Ng, Kenneth S. Chok, Sheung Tat Fan – 28 October 2009 – The native liver of a familial amyloidotic polyneuropathy recipient who undergoes living donor liver transplantation used as a graft for sequential liver transplantation does not include the inferior vena cava. Implantation of this whole liver graft to a second recipient could be simplified by borrowing the experience from right liver living donor liver transplantation.

Adenosine restores the hepatic artery buffer response and improves survival in a porcine model of small‐for‐size syndrome

Dympna M. Kelly, Xiaocheng Zhu, Hiroaki Shiba, Samuel Irefin, Loris Trenti, Andrei Cocieru, Teresa Diago, Lian Fu Wang, Cristiano Quintini, Zhong Chen, Joan Alster, Shunichi Nakagawa, Charles Miller, Anthony Demetris, John J. Fung – 28 October 2009 – The aim of the study is to define the role of the HABR in the pathophysiology of the SFS liver graft and to demonstrate that restoration of hepatic artery flow (HAF) has a significant impact on outcome and improves survival.

Subscribe to